Capital Medica Ventures
Venture capitalTokyo · Pre-Seed–Growth
Also known as 株式会社キャピタルメディカ・ベンチャーズ
What they invest in
from 1 of 1 portfolio companiesAI & Machine Learning ×1Data & Infrastructure ×1Digital Health ×1Healthtech ×1Longevity ×1SaaS ×1
HQs:Japan×1
Investments · 1 tracked
founders shown can be your intro pathRehab for JAPAN develops and provides "Rehab Cloud," a SaaS platform for elderly care and rehabilitation providers, along with "Rehab Studio," an online rehabilitation service, and conducts R&D on AI-based care technology.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechLongevitySaaSTokyo, JP
大久保亮(代表取締役社長 CEO)
Frequently asked questions
- What stage does Capital Medica Ventures invest at?
- Capital Medica Ventures invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Capital Medica Ventures focus on?
- Capital Medica Ventures focuses on Biotech, Healthtech, Medical Devices, SaaS, Sector Agnostic.
- Where is Capital Medica Ventures located?
- Capital Medica Ventures is headquartered in Tokyo, JP.
Similar investors
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
OUP (Osage University Partners) is a venture capital firm that backs science-driven startups commercializing deep technology innovations emerging from university and breakthrough research.